Track record · closed signal

UnitedHealth Group Incorporated (UNH) — closed signal from September 1, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on November 30, 2025.

Predicted vs. what happened

UNH price · publication thesis → realized outcomesplit-adjusted
$305.87 Published $335.13 Target $327.57 Window close $378.46 Peak
$292.31 – $302.05Entry zone — fair-value band
$305.87Published — price the day we called it
$335.13Target — the price the thesis aimed for
$378.46Peak — highest point inside the window, not a realized return
$327.57Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 8 days.

Peak price
$378.46
peak on October 28, 2025 — not a realized return
Peak gain
+23.7%
peak, from the publication price
Window close
$327.57
end-of-window price, context only
Days to target
8
Window
September 1, 2025 – November 30, 2025

The thesis — published September 1, 2025

Predicted growth
+11%
over the measurement window
Target price
$335.13
the price the thesis aimed for
Entry zone
$292.31 – $302.05
the fair-value band we waited for
Price at publication
$305.87
published September 1, 2025
Confidence
60%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UnitedHealth looks strong, but the price has run up fast in the short term. Berkshire Hathaway buying $1.5b worth in Q2 2025 signals smart-money confidence. Some headlines still mention costs tied to loans after a cyberattack, which can weigh on mood. We prefer patience: look to buy on dips within the range instead of paying up. Over the next 3 months, its size and quality should help if the market stays calm.

Primary drivers

  • Berkshire's purchase signals experienced investors believe in the business.
  • Recent strength was rapid; a short breather could set up better entries.
  • Huge size and trusted brand make earnings steadier than many rivals.
  • Lingering loan costs from the cyberattack may still worry some investors.

How it played out

UNH: target reached in 8 days

Lyra published UNH at 305.87 on 2025-09-01 with 11% expected growth and a 335.13 target. The thesis pointed to Berkshire Hathaway's Q2 2025 purchase, recent rapid strength that could need a breather, the company's size and brand, and lingering loan costs from the cyberattack that could still weigh on mood.

Inside the window, UNH reached the target in 8 days. It later peaked at 378.46 on 2025-10-28, with a 23.7% peak gain. By 2025-11-30, it ended at 327.57, below the target. Verdict: the thesis played out, though the final price gave back part of the move.

What happened during the window

On 2025-10-28, UnitedHealth reported third-quarter adjusted earnings of 2.92 per share and revenue of 113.16 billion. It also raised its full-year adjusted earnings outlook to at least 16.25 per share. On 2025-11-18, Reuters reported that former FDA commissioner Scott Gottlieb joined UnitedHealth Group's board.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.